Pharmaceutical company payments to Japanese breast cancer practice guideline authors

Abstract Background The creation of breast cancer practice guidelines requires proper management of financial relationships with drug companies, as they can introduce conflicts of interest (COIs) among guideline authors. However, little is known about the specific landscape and fraction of financial...

Description complète

Détails bibliographiques

Auteurs principaux:	Anju Murayama, Kenichi Higuchi, Keerthana R. Byreddy, Kugo Hinari, Yuki Senoo
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2024-06-01
Collection:	Clinical and Translational Discovery
Sujets:	clinical practice guideline conflicts of interest ethics evidence‐based medicine health policy pharmaceutical companies
Accès en ligne:	https://doi.org/10.1002/ctd2.304
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!